Review



pegfp c3 rab9  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc pegfp c3 rab9
    Pegfp C3 Rab9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/mCherry-Rab11a-7+(Plasmid+%2355124)/pm40174331-61-46-59
    Average 93 stars, based on 24 article reviews
    pegfp c3 rab9 - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: A competition network connects Rab5 and Rab11 GTPases at the surface of endocytic structures
    Article Snippet: p mCherry-Rab11a , Addgene , Cat# 55124; RRID: Addgene_55124.

    Plasmid Preparation:

    Article Title: Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol
    Article Snippet: CHMP2A_GFP_N_term was a gift from Daniel Gerlich (Addgene plasmid # 31805). .. Lamp1-mScarlet-I (Addgene plasmid # 98827) and mScarletI-Rab7 (Addgene plasmid # 112955) were gifts from Dorus Gadella. mCherry-Rab4a-7 (Addgene plasmid # 55125) and mCherry-Rab11a-7 (Addgene plasmid # 55124) were gifts from Michael Davidson. mScarlet-EEA1 (Addgene plasmid # 169067) and GFP-Rab5B (Addgene plasmid # 61802) were gifts from Gia Voeltz. .. GFP-EEA1 wt was a gift from Silvia Corvera (Addgene plasmid # 42307).

    Article Title: MyosinVb tail inhibits transport of Marburg virus glycoprotein GP to VP40-enriched sites at the plasma membrane.
    Article Snippet: Plasmids encoding MARV GP, VP40 and NP as well as EBOV GP under the control of a chicken β-actin promotor (vector pCAGGS) have been described in our previous publication (Wenigenrath et al., 2010). pEGFP vectors were purchased from Clontech Laboratories, Inc. .. The following plasmids were generous gifts from our collaboration partners: pEGFP-Myosin Vb and Vc tail constructs (Richard Cheney, University of North Carolina, references (Desnos et al., 2007; Jacobs et al., 2009; Rodriguez and Cheney, 2002a):); pEGFP-C3-Rab11 (Ralf Jacob, Philipps University Marburg, reference (Cramm-Behrens et al., 2008):); pEGFP-C3-Rab9 (Suzanne Pfeffer, Stanford University, reference (Barbero et al., 2002)); pmCherry-Rab11 (Michael Davidson, Addgene plasmid #55124). .. Generation of pEGFP-Rab5 was performed by subcloning the coding sequence of human Rab5 into the pEGFP-C3 vector (Clontech) via restrictions enzymes BglII and SalI. pCAGGS-MARV-GPΔMLD-mCherry in which the MLD was replaced by mCherry has been characterized previously (Mittler et al., 2018).

    Article Title: Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol.
    Article Snippet: Plasmids, siRNA, mRNA and primers CHMP2A_GFP_N_termwas a gift fromDaniel Gerlich (Addgene plasmid # 31805). .. Lamp1-mScarlet-I (Addgene plasmid # 98827) andmScarletIRab7 (Addgene plasmid # 112955) were gifts from Dorus Gadella. mCherry-Rab4a-7 (Addgene plasmid # 55125) and mCherry-Rab11a-7 (Addgene plasmid # 55124) were gifts from Michael Davidson. mScarlet-EEA1 (Addgene plasmid # 169067) and GFP-Rab5B (Addgene plasmid # 61802) were gifts from Gia Voeltz. .. GFP-EEA1 wt was a gift from Silvia Corvera (Addgene plasmid # 42307).

    Construct:

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes.
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D1R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V2R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V2R, pcDNA3.1-Gαs-long-WT-RlucII(67), pcDNA3.1-Gαsshort-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFPRab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β2AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université deMontréal,Montreal, Canada). pSNAPfβ2AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gαs(C3S)-EGFP and pcDNA3.1-Gαs(C3S) were generated by replacing cysteine with serine at position 3 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1- Communications Biology | (2025) 8:1715 11 Gαs-short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-mini HA were generated with the primers described in Supplementary Table 1 using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gαs-EGFPwas based onHynes et al. with the exception that our construct is human insteadof rat39. pcDNA3.1-Myr-GαsEGFP and pcDNA3.1-Myr-Gαs-long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V 2 R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V 2 R, pcDNA3.1-Gα s -long-WT-RlucII(67), pcDNA3.1-Gα s -short-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFP-Rab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β 2 AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université de Montréal, Montreal, Canada). pSNAPf-β 2 AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gα s (C3S)-EGFP and pcDNA3.1-Gα s (C3S) were generated by replacing cysteine with serine at position 3 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -mini HA were generated with the primers described in Supplementary Table using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gα s -EGFP was based on Hynes et al. with the exception that our construct is human instead of rat . pcDNA3.1-Myr-Gα s -EGFP and pcDNA3.1-Myr-Gα s -long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Article Title: MyosinVb tail inhibits transport of Marburg virus glycoprotein GP to VP40-enriched sites at the plasma membrane.
    Article Snippet: Plasmids encoding MARV GP, VP40 and NP as well as EBOV GP under the control of a chicken β-actin promotor (vector pCAGGS) have been described in our previous publication (Wenigenrath et al., 2010). pEGFP vectors were purchased from Clontech Laboratories, Inc. .. The following plasmids were generous gifts from our collaboration partners: pEGFP-Myosin Vb and Vc tail constructs (Richard Cheney, University of North Carolina, references (Desnos et al., 2007; Jacobs et al., 2009; Rodriguez and Cheney, 2002a):); pEGFP-C3-Rab11 (Ralf Jacob, Philipps University Marburg, reference (Cramm-Behrens et al., 2008):); pEGFP-C3-Rab9 (Suzanne Pfeffer, Stanford University, reference (Barbero et al., 2002)); pmCherry-Rab11 (Michael Davidson, Addgene plasmid #55124). .. Generation of pEGFP-Rab5 was performed by subcloning the coding sequence of human Rab5 into the pEGFP-C3 vector (Clontech) via restrictions enzymes BglII and SalI. pCAGGS-MARV-GPΔMLD-mCherry in which the MLD was replaced by mCherry has been characterized previously (Mittler et al., 2018).

    Generated:

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes.
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D1R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V2R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V2R, pcDNA3.1-Gαs-long-WT-RlucII(67), pcDNA3.1-Gαsshort-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFPRab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β2AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université deMontréal,Montreal, Canada). pSNAPfβ2AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gαs(C3S)-EGFP and pcDNA3.1-Gαs(C3S) were generated by replacing cysteine with serine at position 3 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1- Communications Biology | (2025) 8:1715 11 Gαs-short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-mini HA were generated with the primers described in Supplementary Table 1 using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gαs-EGFPwas based onHynes et al. with the exception that our construct is human insteadof rat39. pcDNA3.1-Myr-GαsEGFP and pcDNA3.1-Myr-Gαs-long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V 2 R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V 2 R, pcDNA3.1-Gα s -long-WT-RlucII(67), pcDNA3.1-Gα s -short-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFP-Rab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β 2 AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université de Montréal, Montreal, Canada). pSNAPf-β 2 AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gα s (C3S)-EGFP and pcDNA3.1-Gα s (C3S) were generated by replacing cysteine with serine at position 3 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -mini HA were generated with the primers described in Supplementary Table using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gα s -EGFP was based on Hynes et al. with the exception that our construct is human instead of rat . pcDNA3.1-Myr-Gα s -EGFP and pcDNA3.1-Myr-Gα s -long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Mutagenesis:

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes.
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D1R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V2R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V2R, pcDNA3.1-Gαs-long-WT-RlucII(67), pcDNA3.1-Gαsshort-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFPRab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β2AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université deMontréal,Montreal, Canada). pSNAPfβ2AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gαs(C3S)-EGFP and pcDNA3.1-Gαs(C3S) were generated by replacing cysteine with serine at position 3 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1- Communications Biology | (2025) 8:1715 11 Gαs-short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-mini HA were generated with the primers described in Supplementary Table 1 using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gαs-EGFPwas based onHynes et al. with the exception that our construct is human insteadof rat39. pcDNA3.1-Myr-GαsEGFP and pcDNA3.1-Myr-Gαs-long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V 2 R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V 2 R, pcDNA3.1-Gα s -long-WT-RlucII(67), pcDNA3.1-Gα s -short-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFP-Rab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β 2 AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université de Montréal, Montreal, Canada). pSNAPf-β 2 AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gα s (C3S)-EGFP and pcDNA3.1-Gα s (C3S) were generated by replacing cysteine with serine at position 3 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -mini HA were generated with the primers described in Supplementary Table using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gα s -EGFP was based on Hynes et al. with the exception that our construct is human instead of rat . pcDNA3.1-Myr-Gα s -EGFP and pcDNA3.1-Myr-Gα s -long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Cloning:

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes.
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D1R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V2R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V2R, pcDNA3.1-Gαs-long-WT-RlucII(67), pcDNA3.1-Gαsshort-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFPRab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β2AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université deMontréal,Montreal, Canada). pSNAPfβ2AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gαs(C3S)-EGFP and pcDNA3.1-Gαs(C3S) were generated by replacing cysteine with serine at position 3 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1- Communications Biology | (2025) 8:1715 11 Gαs-short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-mini HA were generated with the primers described in Supplementary Table 1 using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gαs-EGFPwas based onHynes et al. with the exception that our construct is human insteadof rat39. pcDNA3.1-Myr-GαsEGFP and pcDNA3.1-Myr-Gαs-long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gαs in the construct pcDNA3.1-Gαs-EGFP and pcDNA3.1-Gαs-long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Article Title: Class A and B GPCRs trigger rapid Gα s translocation to late and slow recycling endosomes
    Article Snippet: .. pCMV-15F11-HA-mEGFP (Frankenbody) (#129590), pmRFP-C3-Rab5 (#14437), pmRFP-C3-Rab7 (#55125), mCherry-Rab11a-7 (#55124), and pEGFP-N1-Dyn1(K44A)-mRFP (#55795) constructs were purchased from Addgene. pCDNA3.1-3xHA-D R and pCDNA3.1-HA-Gγ2 were purchased from UMR cDNA Resource Center (University of Missouri-Rolla, Rolla, USA). pRK5-myc-V 2 R, pcDNA3.1-G-Beta-1, pcDNA3.1-PTHR1, pSNAPf-HA-V 2 R, pcDNA3.1-Gα s -long-WT-RlucII(67), pcDNA3.1-Gα s -short-WT-RlucII(119), pcDNA3.1-CAAX-rGFP, pcDNA3.1-Tdr-rGFP-Rab4, pcDNA3.1-Tdr-rGFP-Rab5, pcDNA3.1-Tdr-rGFP-Rab7, pcDNA3.1-Tdr-rGFP-Rab11 and pcDNA3.1-GFP10-EPAC-RlucII, were kindly provided by Dr. Michel Bouvier (Université de Montréal, Montreal, Canada). pcDNA3-Flag-β 2 AR was a gift by Dr. Stéphane Laporte (McGill University, Montreal, Canada) and pmRFP-C3-Rab7 was a gift by Dr. Stéphane Lefrançois (Université de Montréal, Montreal, Canada). pSNAPf-β 2 AR was kindly provided by Dr. Roshanak Irannejad (University of California, San Francisco, USA). pcDNA3.1-Gα s (C3S)-EGFP and pcDNA3.1-Gα s (C3S) were generated by replacing cysteine with serine at position 3 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -short, respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -mini HA were generated with the primers described in Supplementary Table using the Gibson Assembly cloning kit (New England Biolabs). pcDNA3.1-Gα s -EGFP was based on Hynes et al. with the exception that our construct is human instead of rat . pcDNA3.1-Myr-Gα s -EGFP and pcDNA3.1-Myr-Gα s -long-RLucII(67) were generated by adding a threonine at position 4 and a serine at position 6 of Gα s in the construct pcDNA3.1-Gα s -EGFP and pcDNA3.1-Gα s -long-RlucII(67), respectively, using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). .. Isoproterenol (#I6504-100MG), Epinephrine (#E4250), Salmeterol (#94749-08-3), Dobutamine (#D0676), Dopamine (#8502), Parathyroid hormone fragment human 1-34 (PTH1-34) (#P3796) and Anti-Flag rabbit (# F7425) were purchased from Sigma Aldrich (St. Louis, Missouri, USA).

    Injection:

    Article Title: GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinoma.
    Article Snippet: .. For the spontaneous HCC model, plasmids encoding myr-AKT1 (#31 789, Addgene) and N-RasV12 (#20 205, Addgene) along with sleeping beauty transposase (#24 551, Addgene) were delivered into 6- to 8-weekold hGDF15 mice with hydrodynamic injection of myrAKT1 carrying the luciferase gene. ..

    Luciferase:

    Article Title: GFRAL-Fc disarms GDF15 to reprogram tumor immunity and amplify PD-1 efficacy in hepatocellular carcinoma.
    Article Snippet: .. For the spontaneous HCC model, plasmids encoding myr-AKT1 (#31 789, Addgene) and N-RasV12 (#20 205, Addgene) along with sleeping beauty transposase (#24 551, Addgene) were delivered into 6- to 8-weekold hGDF15 mice with hydrodynamic injection of myrAKT1 carrying the luciferase gene. ..



    Similar Products

    93
    Santa Cruz Biotechnology rab9
    Rab9, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/Rab+9+siRNA/pm41274424-80-8-12
    Average 93 stars, based on 1 article reviews
    rab9 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    92
    Cell Signaling Technology Inc rab9
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Rab9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/Rab9+Rabbit+mAb/bio_rxiv__2025__10__31__685804-217-126-130
    Average 92 stars, based on 1 article reviews
    rab9 - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    92
    Cell Signaling Technology Inc rabbit monoclonal anti rab9 d22a6
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Rabbit Monoclonal Anti Rab9 D22a6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/Rab9+Rabbit+mAb/pmc12588189-18-0-5
    Average 92 stars, based on 1 article reviews
    rabbit monoclonal anti rab9 d22a6 - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse anti-rab9
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Mouse Anti Rab9, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/mouse+anti+rab9/pm40562935-1048-39-13
    Average 90 stars, based on 1 article reviews
    mouse anti-rab9 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfleger GmbH venus-rab9
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Venus Rab9, supplied by Pfleger GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/venus+rab9/pmc12159506-82-0-3
    Average 90 stars, based on 1 article reviews
    venus-rab9 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    93
    Addgene inc pegfp c3 rab9
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Pegfp C3 Rab9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/mCherry-Rab11a-7+(Plasmid+%2355124)/pm40174331-61-46-59
    Average 93 stars, based on 1 article reviews
    pegfp c3 rab9 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    ABclonal Biotechnology anti rab9
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Anti Rab9, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/RAB9A+Rabbit+pAb/pm40197538-267-39-41
    Average 93 stars, based on 1 article reviews
    anti rab9 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Addgene inc gfprab9 wt
    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or <t>RAB9</t> KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.
    Gfprab9 Wt, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rab9/GFP-rab9+WT+(Plasmid+%2312663)/10__1016_slash_j__bbrc__2025__151800-62-29-34
    Average 93 stars, based on 1 article reviews
    gfprab9 wt - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or RAB9 KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.

    Journal: bioRxiv

    Article Title: ER-to-Golgi Trafficking is a Nutrient-Sensitive Checkpoint Linking Glucose Starvation to Cell Surface Remodeling

    doi: 10.1101/2025.10.31.685804

    Figure Lengend Snippet: (a–f) U2OS cells (wild-type [WT], ULK1/2 double knockout [DKO], ATG7 knockout [KO], or RAB9 KO were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in Dulbecco’s Modified Eagle Medium (DMEM) with or without glucose for 1 h, followed by biotin treatment for 30 min. ( a ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( b ) Percentage of cells (mean ± S.E.M., n = 3 biological replicates, >37 cells per replicate) with Golgi-localized E-cadherin. ( c–f ) Representative immunoblot analyses show protein levels of ULK1, ULK2, ATG7, or RAB9 in WT and indicated KO cell lines; * indicates nonspecific band in ( e ). ( g–i ) Rescue of glucose starvation–induced ER-to-Golgi trafficking inhibition was evaluated in U2OS ULK1/2 DKO cells stably expressing empty vector (EV), WT ULK1, kinase-dead ULK1 (K46A), or AMPK-resistant ULK1 (4SA). Cells were transfected with the E-cadherin RUSH construct, incubated in DMEM with or without glucose for 1 h, and treated with biotin for 30 min. ( g ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( h ) Golgi-localized E-cadherin in U2OS ULK1/2 DKO cells expressing WT or mutant forms of ULK (mean ± S.E.M., n = 3 biological replicates, >30 cells per replicate). ( i ) Representative immunoblot analysis shows AMPK activity as indicated by total and phospho-ACC, and ULK1 expression, and AMPK-mediated phosphorylation of ULK1 at S555 in the indicated cell lines. ( j–l ) WT U2OS cells were transfected with the E-cadherin RUSH construct. After 48 h, cells were pre-treated with compound C (5 μM, 4 h) or MRT68921 (1 μM, 24 h) and incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( j ) Representative immunofluorescence images following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( k ) Golgi-localized E-cadherin in U2OS cells before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >103 cells per replicate). ( l ) Representative immunoblot analysis demonstrates activity of each inhibitor post biotin treatment. ( m–o ) WT or Prkaa1/2 (AMPKα1/2) DKO murine embryonic fibroblasts (MEFs) were transfected with the E-cadherin RUSH construct. After 48 h, cells were incubated in DMEM with or without glucose for 1 h, followed by biotin treatment for 30 min. ( m ) Representative immunofluorescence images captured following anti-GM130 and DAPI staining show changes in reporter distribution after biotin addition and/or glucose starvation. ( n ) Golgi-localized E-cadherin in in WT and AMPK α1/2 DKO MEFs before and after glucose starvation (mean ± S.E.M., n = 3 biological replicates, >33 cells per replicate). ( o ) Levels of phosphorylated ACC and ULK1 in WT and AMPK α1/2 DKO MEFs after 1-h glucose starvation. Statistical significance was analyzed with one-way ANOVA followed by Tukey’s multiple comparisons. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Scale bar, 10 μm.

    Article Snippet: After blocking the membrane with 5% skim milk, blots were probed with antibodies directed against the following targets: ULK1 (Cat. No. 8058, Cell Signaling), p-ULK1 (S555) (Cat. No. 5869, Cell Signaling), ATG7 (Cat. No. 2631, Cell Signaling), ULK2 (Cat. No. HPA009027, Sigma-Aldrich), ATG13 (Cat. No. SAB4200100, Millipore Sigma), p-ATG13 (S318) (Cat. No. 600-401-C49 Rockland), GFP (Cat. No. ab6556, Abcam), FLAG (Cat. No. F1804, Millipore Sigma), HA (Cat. No. 3724, Cell Signaling), GAPDH (Cat. No. G9545, Sigma Aldrich), p-ACC (S79) (Cat. No. 11818, Cell Signaling), ACC (Cat. No. 3676, Cell Signaling), p-S6 (S235/236) (Cat. No. 4858, Cell Signaling), S6 (Cat. No. 2317, Cell Signaling), SEC24C (Cat. No. 8531, Cell Signaling), SEC24A (Cat. No. 15958-1-AP, Proteintech), SEC24B (Cat. No. A304-876A, Bethyl), SEC24D (Cat. No. 14687, Cell Signaling), and RAB9 (Cat. No. 5133, Cell Signaling).

    Techniques: Double Knockout, Knock-Out, Transfection, Construct, Incubation, Modification, Immunofluorescence, Staining, Western Blot, Inhibition, Stable Transfection, Expressing, Plasmid Preparation, Mutagenesis, Activity Assay, Phospho-proteomics